GB201819126D0 - Inhibitor compounds - Google Patents
Inhibitor compoundsInfo
- Publication number
- GB201819126D0 GB201819126D0 GBGB1819126.2A GB201819126A GB201819126D0 GB 201819126 D0 GB201819126 D0 GB 201819126D0 GB 201819126 A GB201819126 A GB 201819126A GB 201819126 D0 GB201819126 D0 GB 201819126D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- inhibitor compounds
- inhibitor
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1819126.2A GB201819126D0 (en) | 2018-11-23 | 2018-11-23 | Inhibitor compounds |
| PCT/GB2019/053314 WO2020104820A1 (en) | 2018-11-23 | 2019-11-22 | Substituted benzimidazolones as anti-cancer agents |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1819126.2A GB201819126D0 (en) | 2018-11-23 | 2018-11-23 | Inhibitor compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201819126D0 true GB201819126D0 (en) | 2019-01-09 |
Family
ID=65024360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1819126.2A Ceased GB201819126D0 (en) | 2018-11-23 | 2018-11-23 | Inhibitor compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201819126D0 (en) |
| WO (1) | WO2020104820A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3192868A1 (en) * | 2020-09-24 | 2022-03-31 | Auckland Uniservices Limited | Novel aminopyridines and their use in treating cancer |
| GB202117224D0 (en) * | 2021-11-29 | 2022-01-12 | Neophore Ltd | Inhibitor compounds |
| WO2023240038A1 (en) | 2022-06-06 | 2023-12-14 | Treeline Biosciences, Inc. | Tricyclic quinolone bcl6 bifunctional degraders |
| WO2023244918A1 (en) | 2022-06-13 | 2023-12-21 | Treeline Biosciences, Inc. | Quinolone bcl6 bifunctional degraders |
| WO2023244917A1 (en) | 2022-06-13 | 2023-12-21 | Treeline Biosciences, Inc. | 1,8-naphthyridin-2-one heterobifunctional bcl6 degraders |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| TR199801530T2 (en) | 1996-02-13 | 1998-11-23 | Zeneca Limited | Quinazoline derivatives as VEGF inhibitors. |
| PT885198E (en) | 1996-03-05 | 2002-06-28 | Astrazeneca Ab | 4-ANYLINOQUINAZOLINE DERIVATIVES |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| HU230000B1 (en) | 1999-02-10 | 2015-04-28 | Astrazeneca Ab | Intermediates for the preparation of angiogenesis inhibitory quinazoline derivatives |
| JP2003535078A (en) | 2000-05-31 | 2003-11-25 | アストラゼネカ アクチボラグ | Indole derivatives with vascular damage activity |
| UA73993C2 (en) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Quinazoline derivatives for the treatment of tumours and a pharmaceutical composition |
| EE200300015A (en) | 2000-07-07 | 2004-10-15 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as inhibitors of angiogenesis |
| NZ522861A (en) | 2000-07-07 | 2004-07-30 | Angiogene Pharm Ltd | Colchinol derivatives as vascular damaging agents |
| WO2018108704A1 (en) * | 2016-12-13 | 2018-06-21 | Boehringer Ingelheim International Gmbh | New 6-amino-quinolinone compounds and derivatives as bcl6 inhibitors |
| CA3065005A1 (en) * | 2017-05-26 | 2018-11-29 | Cancer Research Technology Limited | Benzimidazolone derived inhibitors of bcl6 |
| US11161839B2 (en) * | 2017-05-26 | 2021-11-02 | The Institute Of Cancer Research: Royal Cancer Hospital | 2-quinolone derived inhibitors of BCL6 |
-
2018
- 2018-11-23 GB GBGB1819126.2A patent/GB201819126D0/en not_active Ceased
-
2019
- 2019-11-22 WO PCT/GB2019/053314 patent/WO2020104820A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020104820A1 (en) | 2020-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283639A (en) | Kif18a inhibitors | |
| GB201705971D0 (en) | Inhibitor compounds | |
| GB201810092D0 (en) | Compounds | |
| GB201805174D0 (en) | Compounds | |
| GB201801355D0 (en) | Compounds | |
| GB201807924D0 (en) | Compounds | |
| GB201819126D0 (en) | Inhibitor compounds | |
| IL290087A (en) | Inhibitor compounds | |
| GB201810581D0 (en) | Compounds | |
| IL276013A (en) | Pi4kiiibeta inhibitors | |
| GB201808093D0 (en) | Compounds | |
| GB201914860D0 (en) | Inhibitor compounds | |
| FI3810633T3 (en) | Compounds | |
| GB201809102D0 (en) | Compounds | |
| IL281514A (en) | O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors | |
| GB201810071D0 (en) | Compounds | |
| GB201803340D0 (en) | Compounds | |
| GB201801128D0 (en) | Compounds | |
| GB201801130D0 (en) | Compounds | |
| GB201819136D0 (en) | Inhibitor compounds | |
| GB201806130D0 (en) | Inhibitor compounds | |
| GB201806131D0 (en) | Inhibitor compounds | |
| GB201905318D0 (en) | Inhibitor compounds | |
| GB201905328D0 (en) | Inhibitor compounds | |
| GB201809939D0 (en) | Eastase inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |